Henry Huang

Address:

15038 Un Tpke, Flushing, NY 11367

Phone:

347 933-0788

VIN:

WDDHF8HB8BA294613

Make:

MERCEDES-BENZ

Model:

E-CLASS

Year:

2011

US Patent:

20100028207, Feb 4, 2010

Filed:

Jul 15, 2009

Appl. No.:

12/503665

Inventors:

Gregory M. Colella - Montclair NJ, US
Henry D. Huang - Edison NJ, US
Dimitri V. Shishkin - Whippany NJ, US
Maria Figueroa - Elizabeth NJ, US
James A. Mawhirt - Brooklyn NY, US

Assignee:

International Technidyne Corporation - Piscataway NJ

International Classification:

G01N 33/49
B01L 3/00

US Classification:

422 73, 422102

Abstract:

An apparatus for measuring blood clotting time includes a blood clot detection instrument and a cuvette for use with the blood clot detection instrument. The cuvette includes a blood sample receptor-inlet; a channel arrangement including at least one test channel for performing a blood clotting time measurement, a sampling channel having at least one surface portion that is hydrophilic, communicating with the blood sample receptor-inlet and the at least one test channel, and a waste channel having at least one surface portion that is hydrophilic, communicating with the sampling channel; and a vent opening communicating with the sampling channel. The sampling channel, the vent opening and the waste channel, coact to automatically draw a requisite volume of a blood sample deposited at the blood receptor-inlet, into the sampling channel. More specifically, air compressed within the blood clot detection instrument, the at least one test channel of the cuvette, and the section of the sampling channel extending beyond the vent opening of the cuvette, coacts with the waste channel to cause a leading edge of the blood sample drawn into the sampling channel from the blood receptor-inlet, to pull back within the sampling channel and uncover an optical sensor in of the blood clot detection instrument. The uncovering of the optical sensor activates a pump module of the blood clot detection instrument, which draws the requisite volume of the blood sample into the at least one test channel.

US Patent:

20130017126, Jan 17, 2013

Filed:

May 17, 2012

Appl. No.:

13/474243

Inventors:

Gregory M. Colella - Montclair NJ, US
Henry D. Huang - Edison NJ, US
Dimitri Shishkin - Whippany NJ, US
Maria Figueroa - Elizabeth NJ, US
James A. Mawhirt - Brooklyn NY, US

Assignee:

INTERNATIONAL TECHNIDYNE CORPORATION - Piscataway NJ

International Classification:

G01N 33/49
B01L 3/00

US Classification:

422501, 422 73

Abstract:

An apparatus for measuring blood clotting time includes a blood clot detection instrument and a cuvette for use with the blood clot detection instrument. The cuvette includes a blood sample receptor-inlet; a channel arrangement including at least one test channel for performing a blood clotting time measurement, a sampling channel having at least one surface portion that is hydrophilic, communicating with the blood sample receptor-inlet and the at least one test channel, and a waste channel having at least one surface portion that is hydrophilic, communicating with the sampling channel; and a vent opening communicating with the sampling channel. The sampling channel, the vent opening and the waste channel, coact to automatically draw a requisite volume of a blood sample deposited at the blood receptor-inlet, into the sampling channel.

US Patent:

55322140, Jul 2, 1996

Filed:

Jul 14, 1994

Appl. No.:

8/275327

Inventors:

Sylvia Lee-Huang - New York NY
Philip L. Huang - Boston MA
Hao-chia Chen - Potomac MD
Hsiang-fu Kung - Middletown MD
Peter Huang - New York NY
Henry I. Huang - New York NY
Paul L. Huang - Boston MD

Assignee:

New York University - New York NY
American Biosciences, Inc. - Boston MA
The United States of America as represented by the Department of Health
and Human Services - Washington DC

International Classification:

A61K 3802

US Classification:

214 2

Abstract:

A new protein, termed TAP 29, obtainable from the root tuber of the plant Trichosanthes kirilowii or produced by recombinant means is useful for treating HIV infections or tumors. In treating HIV infections, the protein is administered alone or in conjunction with conventional AIDS therapies. Also provided are processes for purifying the protein, DNA sequences encoding the protein, hosts expressing the protein, recombinant DNA methods for expressing the protein, and antibodies specific for the protein.

US Patent:

54848890, Jan 16, 1996

Filed:

Jul 21, 1994

Appl. No.:

8/277283

Inventors:

Sylvia Lee-Huang - New York NY
Philip L. Huang - Boston MA
Peter L. Nara - Frederick MD
Hao-Chia Chen - Potomac MD
Hsiang-fu Kung - Middletown MD
Peter Huang - New York NY
Henry I. Huang - New York NY
Paul L. Huang - Boston MA

Assignee:

New York University - New York NY
American Biosciences, Inc. - Boston MA
The United States of America as represented by the Secretary of the
Department of Health and Human Services - Washington DC

International Classification:

C07K 14415

US Classification:

530379

Abstract:

A protein, in particular MAP 30, obtainable from both the fruit and seeds of Momordica charantia or produced by recombinant means useful for treating tumors and HIV infections is disclosed. In treating HIV infections, the protein is administered alone or in conjunction with conventional AIDS therapies. Also provided are processes for purifying the protein, DNA sequences encoding the protein, and recombinant DNA methods for expressing the protein.

US Patent:

53170091, May 31, 1994

Filed:

Aug 26, 1991

Appl. No.:

7/749541

Inventors:

Sylvia Lee-Huang - New York NY
Hsiang-fu Kung - Middletown MD
Paul L. Huang - Boston MA
Philip L. Huang - Boston MA
Peter Huang - New York NY
Henry I. Huang - New York NY
Hao-chia Chen - Potomac MD

Assignee:

New York University - New York NY
American Biosciences, Inc. - Boston MA
National Institutes of Health - Bethesda MD

International Classification:

C07K 1300
C07K 1510
C07K 1514

US Classification:

514 8

Abstract:

New proteins, termed GAP 31, obtainable from the seeds of Gelonium multiflorum, and DAP 30 and DAP 32, obtainable from the leaves or seeds of Dianthus caryophyllus, or the above proteins produced by recombinant means, are useful for treating HIV infections. In treating HIV infections, the protein is administered alone or in conjunction with other anti-HIV therapeutics. Also provided are processes for purifying the proteins, DNA sequences encoding the proteins, hosts expressing the proteins, recombinant DNA methods for expressing the proteins, and antibodies specific for the proteins.

US Patent:

20220342912, Oct 27, 2022

Filed:

Jan 19, 2022

Appl. No.:

17/579267

Inventors:

- New York NY, US
Henry HUANG - New York NY, US
Michael REID - Irvine CA, US
Pradnesh DESHMUKH - Mumbai, IN
Vasundhara RUNGTA - Mumbai, IN
Prachi AGRAWAL - Mumbai, IN
Pranati DANG - Bangalore, IN
Tarun SHARMA - San Jose CA, US
Vasudeva SANKARANARAYANAN - Chicago IL, US
Surya TURLAPATI - Bangalore, IN
Mathew GEORGE - Bangalore, IN

Assignee:

PricewaterhouseCoopers LLP - New York NY

International Classification:

G06F 16/28
G06F 16/2458

Abstract:

Systems, methods, and graphical user interfaces (GUIs) for ingesting and enriching data regarding a plurality of entities are provided. A first data set comprising company data and a second data set comprising customer data are ingested. The first data set is processed to generate a processed data set. The first data set may be processed by applying an entity matching technique, wherein one or more data elements are generated based on whether an entity of the first data set and an entity of the second data set are commonly associated. The first data set may additionally or alternatively be processed by applying a statistical matching technique, wherein one or more predicted data elements are generated based on similarity between an entity of the first data set and one or more entities of the second data set.